Fredman Lab

Albany Medical College, Department of Molecular and Cellular Physiology


Gerlach BD, Marinello M, Heinz J, Rymut N, Sansbury BE, Riley CO, Sadhu S, Hosseini Z, Kojima Y, Tang DD, Leeper NJ, Spite M, Barroso M, Rayner KJ, Fredman G. Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death Differ. 2019 Jun 20. doi: 10.1038/s41418-019-0370-1. (PMID:31222041)

Fredman G, Hellmann J, Proto JD, Kuriakose G, Colas RA, Dorweiler B, Connolly ES, Solomon R, Jones DM, Heyer EJ, Spite M and Tabas I. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. 2016. Nat Commun. 7:12859 doi:10.1038/ncomms12859

Cai B, Thorp EB, Doran AC, Subramanian M, Lin C, Fredman G*, Tabas I.* MerTK cleavage limits pro-resolving mediator biosynthesis and exacerbates tissue inflammation. 2016. PNAS. (PMID: 27199481)

Fredman G, Kamaly N, Spolitu S, Milton J, Ghorpade D, Chiasson R, Kuriakose G, Perretti M, Farokhzad O, Tabas I. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. 2015. Sci. Transl. Med. Feb 18;7(275):275ra20. (PMID: 25695999). *featured as the cover

Fredman G, Ozcan L, Spolitu S, Tabas I. Resolvin D1 limits 5-LOX nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated pathway. 2014. PNAS. Oct 7;111(40):14530-5. (PMID: 25246560). 

For a complete list of publications, click here